Beneficiary: Benaroya Research Institute

The world-renowned, nonprofit Benaroya Research Institute at Virginia Mason (BRI) is committed to finding causes and cures for diseases of the immune system. BRI uniquely studies the immune system in both health and disease, accelerating discovery through lab breakthroughs that can be translated to clinical therapies. Diseases we study include type 1 diabetes, rheumatoid arthritis, lupus, multiple sclerosis, Crohn's and colitis as well as allergies, asthma and COVID-19. BRI advances the science to predict, prevent, reverse and cure diseases of the immune system to achieve our vision of a healthy immune system for every individual.